<!doctype html><html lang=tw><head><meta charset=utf-8><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=viewport content="width=device-width,initial-scale=1"><meta name=referrer content="no-referrer"><link rel=dns-prefetch href=https://i.geekbank.cf/><title>SGLT-2 抑制劑和 GLP-1 受體激動劑的區別與選用 | 极客快訊</title><meta property="og:title" content="SGLT-2 抑制劑和 GLP-1 受體激動劑的區別與選用 - 极客快訊"><meta property="og:type" content="article"><meta property="og:locale" content="tw"><meta property="og:image" content="https://p3.pstatp.com/large/pgc-image/70ac3fd9437640c68f63b742d73fd752"><link rel=alternate hreflang=x-default href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%b8/73c2479.html><link rel=alternate hreflang=zh-tw href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%b8/73c2479.html><link rel=alternate hreflang=zh-cn href=https://geekbank.cf/cn/%e7%a7%91%e5%ad%b8/73c2479.html><link rel=alternate hreflang=zh-hk href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%b8/73c2479.html><link rel=alternate hreflang=zh-mo href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%b8/73c2479.html><link rel=alternate hreflang=zh-my href=https://geekbank.cf/cn/%e7%a7%91%e5%ad%b8/73c2479.html><link rel=alternate hreflang=zh-sg href=https://geekbank.cf/cn/%e7%a7%91%e5%ad%b8/73c2479.html><link rel=canonical href=https://geekbank.cf/tw/%e7%a7%91%e5%ad%b8/73c2479.html><meta property="article:published_time" content="2020-10-29T20:57:49+08:00"><meta property="article:modified_time" content="2020-10-29T20:57:49+08:00"><meta name=Keywords content><meta name=description content="SGLT-2 抑制劑和 GLP-1 受體激動劑的區別與選用"><meta name=author content="极客快訊"><meta property="og:url" content="/tw/%E7%A7%91%E5%AD%B8/73c2479.html"><link rel=apple-touch-icon sizes=180x180 href=../../apple-touch-icon.png><link rel=icon type=image/png sizes=32x32 href=../../favicon-32x32.png><link rel=icon type=image/png sizes=16x16 href=../../favicon-16x16.png><link rel=manifest href=../../site.webmanifest><link rel=mask-icon href=../../safari-pinned-tab.svg color=#5bbad5><meta name=msapplication-TileColor content="#ffc40d"><meta name=theme-color content="#ffffff"><link rel=stylesheet href=https://geekbank.cf/css/normalize.css><link rel=stylesheet href=https://geekbank.cf/css/style.css><script type=text/javascript src=https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js></script><script type=text/javascript src=https://geekbank.cf/js/jqthumb.min.js></script><script data-ad-client=ca-pub-3525055026201463 async src=https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js></script></head><body><header id=header class=clearfix><div class=container><div class=col-group><div class=site-name><h1><a id=logo href>🤓 极客快訊 Geek Bank</a></h1><p class=description>為你帶來最全的科技知識 🧡</p></div><div><nav id=nav-menu class=clearfix><a class=current href>猜你喜歡</a>
<a href=../../tw/categories/%E7%A7%91%E6%8A%80.html title=科技>科技</a>
<a href=../../tw/categories/%E9%81%8A%E6%88%B2.html title=遊戲>遊戲</a>
<a href=../../tw/categories/%E7%A7%91%E5%AD%B8.html title=科學>科學</a></nav></div></div></div></header><div id=body><div class=container><div class=col-group><div class=col-8 id=main><div class=res-cons><article class=post><header><h1 class=post-title>SGLT-2 抑制劑和 GLP-1 受體激動劑的區別與選用</h1></header><date class="post-meta meta-date">2020-10-29</date><div class=post-meta><span>|</span>
<span class=meta-category><a href=tw/categories/%E7%A7%91%E5%AD%B8.html>科學</a></span></div><div class=post-content><p><br></p><p>糖尿病是因胰島素分泌絕對不足或相對不足，引起漸進性糖、脂肪、蛋白質、水和電解質紊亂的疾病，以高血糖為主要標誌，可分為 1 型糖尿病、2 型糖尿病、妊娠糖尿病（GDM）和特殊類型糖尿病 4 類。</p><p>動脈粥樣硬化性心血管疾病（ASCVD）和/或慢性腎臟疾病（CKD）是 2 型糖尿病（T2DM）常見合併疾病及致殘和致死的首要原因。新型降糖藥物鈉-葡萄糖共轉運蛋白 2（SGLT-2）抑制劑、胰高糖素樣肽 1（GLP-1）受體激動劑可顯著改善心血管和腎臟結局，那麼臨床如何使用呢？</p><p><strong>一、SGLT-2 抑制劑和 GLP-1 受體激動劑的比較</strong></p><p>SGLT-2 抑制劑和 GLP-1 受體激動劑均有利尿、排鈉、減輕體重、降低血壓和減輕血管炎症的作用。</p><p>（1）SGLT-2 抑制劑</p><p>SGLT-2 抑制劑為口服類降糖藥物，如達格列淨、恩格列淨和卡格列淨，通過抑制腎臟近曲小管重吸收葡萄糖的 SGLT-2 活性，增加尿液中葡萄糖排洩而降糖，其降糖作用呈血糖水平依賴性，降糖療效近似於二甲雙胍而優於磺脲類藥物及 DPP-4 抑制劑，並增加水鈉和尿酸的排出，且減少內臟脂肪（對骨骼肌影響小）、減輕體重和降低血壓，還可降低血容量、提高射血分數、增加心臟能量底物（酮體，遊離脂肪酸）。</p><p>SGLT-2 抑制劑單獨使用時不增加或極少致低血糖風險，聯合胰島素或胰島素促泌劑（如磺脲類藥物和格列脲類藥物）時，可增加低血糖發生風險。</p><div class=pgc-img><img alt="SGLT-2 抑制劑和 GLP-1 受體激動劑的區別與選用" onerror=errorimg.call(this); src=https://p3.pstatp.com/large/pgc-image/70ac3fd9437640c68f63b742d73fd752><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><p>（2）GLP-1 受體激動劑</p><p>GLP-1 受體激動劑主要是注射類降糖藥物，如利拉魯肽、司美魯肽、度拉糖肽，均需皮下注射，司美魯肽有口服制劑。</p><p>其通過激活體內 GLP-1 受體發揮降糖效應，以葡萄糖濃度依賴的方式增強胰島素分泌及抑制胰高糖素分泌，並可延緩胃排空、抑制食慾中樞減少進食量，同時可有效降低空腹和餐後血糖、降低體重/血壓/甘油三酯，更適於胰島素抵抗、腹型肥胖的糖尿病者。</p><p>與磺脲類藥物、噻唑烷二酮類（TZDs）藥物及甘精胰島素相比，GLP-1 受體激動劑有更強或相當的降低 HbA1C 的能力，但其降體重效果明顯優於以上藥物。GLP-1 受體激動劑單獨使用極少增加低血糖發生的風險。</p><p></p><div class=pgc-img><img alt="SGLT-2 抑制劑和 GLP-1 受體激動劑的區別與選用" onerror=errorimg.call(this); src=https://p3.pstatp.com/large/pgc-image/5f484c1f5d1448b9a4eab1868105daab><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><div class=pgc-img><img alt="SGLT-2 抑制劑和 GLP-1 受體激動劑的區別與選用" onerror=errorimg.call(this); src=https://p9.pstatp.com/large/pgc-image/3d27f7cbf16f474ba98b2f0b016633f3><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><div class=pgc-img><img alt="SGLT-2 抑制劑和 GLP-1 受體激動劑的區別與選用" onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/d8f275ee2b7c403caef77ddc450db201><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><p><strong>二、SGLT-2抑制劑和GLP-1受體激動劑的選用</strong></p><p>SGLT-2 抑制劑對合並 ASCVD 或心血管高風險因素的 T2DM 者，有明確的改善心血管結局的作用，其中對心力衰竭的改善尤為突出，同時對腎臟有保護作用。GLP-1 受體激動劑對 T2DM 合併 ASCVD 或危險因素者，能延緩心血管疾病和腎臟疾病的進展，保護心腦血管及腎臟。</p><div class=pgc-img><img alt="SGLT-2 抑制劑和 GLP-1 受體激動劑的區別與選用" onerror=errorimg.call(this); src=https://p9.pstatp.com/large/pgc-image/d7eb551accf44614b9bb95431540bfb9><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><div class=pgc-img><img alt="SGLT-2 抑制劑和 GLP-1 受體激動劑的區別與選用" onerror=errorimg.call(this); src=https://p1.pstatp.com/large/pgc-image/b32964e0a25e4086a1bc0def32dea5e8><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><div class=pgc-img><img alt="SGLT-2 抑制劑和 GLP-1 受體激動劑的區別與選用" onerror=errorimg.call(this); src=https://p3.pstatp.com/large/pgc-image/b7304b91ba3a4c3aba033876359404e4><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p><p><strong>三、SGLT-2 抑制劑和 GLP-1 受體激動劑使用的注意事項</strong></p><p>SGLT-2 抑制劑和 GLP-1 受體激動劑安全性和耐受性好，但在使用過程中仍應注意相關不良反應與用藥禁忌。</p><div class=pgc-img><img alt="SGLT-2 抑制劑和 GLP-1 受體激動劑的區別與選用" onerror=errorimg.call(this); src=https://p3.pstatp.com/large/pgc-image/4342a182f74b4caf95c6c6e4f5ec68e6><div class=pgc-img-handler><div class="pgc-img-button editorImage fix-android"><section></section></div><div class="pgc-img-button setImageCover fix-android"><section></section></div><div class="pgc-img-button deleteImage fix-android"><section></section></div></div><div class=pgc-img-border></div></div><p><br></p></div><div class="post-meta meta-tags"><ul class=clearfix><li><a>SGLT</a></li><li><a>GLP</a></li><li><a>受體</a></li></ul></div></article></div></div><div id=secondary><section class=widget><form id=search action=//www.google.com/search method=get accept-charset=utf-8 target=_blank _lpchecked=1><input type=text name=q maxlength=20 placeholder=搜索>
<input type=hidden name=sitesearch value=geekbank.cf>
<button type=submit>🔍</button></form></section><section class=widget><h3 class=widget-title>最新文章 ⚡</h3><ul class=widget-list><li><a href=../../tw/%E7%A7%91%E5%AD%B8/ab8f1ef.html alt=淺談口服GLP-1受體激動劑 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p9.pstatp.com/large/594800007c64be437a60 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/ab8f1ef.html title=淺談口服GLP-1受體激動劑>淺談口服GLP-1受體激動劑</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/b0bec2c.html alt="降低體重的GLP-1受體激動劑，體重正常的患者可以用嗎？| 研究速遞" class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/Rf52M4V8uZJFyr style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/b0bec2c.html title="降低體重的GLP-1受體激動劑，體重正常的患者可以用嗎？| 研究速遞">降低體重的GLP-1受體激動劑，體重正常的患者可以用嗎？| 研究速遞</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/78eb0d6.html alt=「關注前沿」新型降糖藥GLP-1受體激動劑（一）——從每日一次到每週一次 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/RU56QNi4qFcuuM style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/78eb0d6.html title=「關注前沿」新型降糖藥GLP-1受體激動劑（一）——從每日一次到每週一次>「關注前沿」新型降糖藥GLP-1受體激動劑（一）——從每日一次到每週一次</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/cc91adc.html alt=三分鐘，帶你全面瞭解GLP-1受體激動劑 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/RebKOuvZMQlfD style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/cc91adc.html title=三分鐘，帶你全面瞭解GLP-1受體激動劑>三分鐘，帶你全面瞭解GLP-1受體激動劑</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/9505d84.html alt=降血糖新藥GLP-1受體激動劑，目前國內上市8種，你瞭解幾種 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/19d80a2f211b46b4a55fce73acf876ea style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/9505d84.html title=降血糖新藥GLP-1受體激動劑，目前國內上市8種，你瞭解幾種>降血糖新藥GLP-1受體激動劑，目前國內上市8種，你瞭解幾種</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/906b55ee.html alt=西安楊森新一代雄激素受體抑制劑安森珂在華上市 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p3.pstatp.com/large/pgc-image/Rj0wRlBHXZZhEC style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/906b55ee.html title=西安楊森新一代雄激素受體抑制劑安森珂在華上市>西安楊森新一代雄激素受體抑制劑安森珂在華上市</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/0bc8098d.html alt=β受體阻滯劑50週年——心力衰竭篇 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p3.pstatp.com/large/pgc-image/RVFqME0AMu1NFu style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/0bc8098d.html title=β受體阻滯劑50週年——心力衰竭篇>β受體阻滯劑50週年——心力衰竭篇</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/f2ee5885.html alt=β受體阻滯劑，治療心力衰竭的“金三角”藥物之一 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/dfic-imagehandler/4b5c4ceb-ff1e-425c-861b-68195ff3a2ec style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/f2ee5885.html title=β受體阻滯劑，治療心力衰竭的“金三角”藥物之一>β受體阻滯劑，治療心力衰竭的“金三角”藥物之一</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/887e7556.html alt=降壓藥受體阻滯劑，如何選用？ class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/887e7556.html title=降壓藥受體阻滯劑，如何選用？>降壓藥受體阻滯劑，如何選用？</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/61d1f060.html alt=受體研究揭示新冠中間宿主範圍比SARS窄，穿山甲概率低 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p9.pstatp.com/large/pgc-image/S23IMcn25zcFdL style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/61d1f060.html title=受體研究揭示新冠中間宿主範圍比SARS窄，穿山甲概率低>受體研究揭示新冠中間宿主範圍比SARS窄，穿山甲概率低</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/50fbd8a.html alt=T淋巴細胞、外周免疫器官、免疫記憶、表面抗原、受體、表面受體 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p3.pstatp.com/large/pgc-image/fad42260323040d28dfb0868e9282b76 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/50fbd8a.html title=T淋巴細胞、外周免疫器官、免疫記憶、表面抗原、受體、表面受體>T淋巴細胞、外周免疫器官、免疫記憶、表面抗原、受體、表面受體</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/9c1c3af.html alt=T細胞受體抗原識別機制研究取得進展 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p9.pstatp.com/large/pgc-image/RII51A7GPSybNN style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/9c1c3af.html title=T細胞受體抗原識別機制研究取得進展>T細胞受體抗原識別機制研究取得進展</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/db1b20a.html alt=抗磷脂酶A2受體抗體在膜性腎病診治中的作用 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/db1b20a.html title=抗磷脂酶A2受體抗體在膜性腎病診治中的作用>抗磷脂酶A2受體抗體在膜性腎病診治中的作用</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/d92725b.html alt=「藥我說」常見β2受體激動劑在平喘中的應用 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p3.pstatp.com/large/pgc-image/R6YArgeExxjCoi style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/d92725b.html title=「藥我說」常見β2受體激動劑在平喘中的應用>「藥我說」常見β2受體激動劑在平喘中的應用</a></li><hr><li><a href=../../tw/%E7%A7%91%E5%AD%B8/cadde06.html alt=哮喘發作時使用的平喘藥，2受體激動劑 class="image featured" style=display:block;margin-left:auto;margin-right:auto;width:100%><img src=https://p1.pstatp.com/large/pgc-image/1526206366630d5f20202c3 style=border-radius:25px></a>
<a href=../../tw/%E7%A7%91%E5%AD%B8/cadde06.html title=哮喘發作時使用的平喘藥，2受體激動劑>哮喘發作時使用的平喘藥，2受體激動劑</a></li><hr></ul></section><section class=widget><h3 class=widget-title>其他</h3><ul class=widget-list><li><a href=TOS.html>使用條款</a></li><li><a href=CommentPolicy.html>留言政策</a></li><li><a href=mailto:gdnews@tuta.io rel=nofollow>DMCA</a></li><li><a href=mailto:gdnews@tuta.io rel=nofollow>聯絡我們</a></li></ul></section></div></div></div></div><footer id=footer><div class=container>&copy; 2020 <a href>极客快訊</a></div></footer><script type=text/javascript>window.MathJax={tex2jax:{inlineMath:[['$','$']],processEscapes:true}};</script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.5/MathJax.js?config=TeX-MML-AM_CHTML" async></script><a id=rocket href=#top></a><script type=text/javascript src=https://kknews.cf/js/totop.js async></script><script type=text/javascript src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-5e508ed9e4e698bb"></script></body></html>